Erschienen in:
01.07.2008 | original article
Responsiveness and Minimal Clinically Important Differences after Cholecystectomy: GIQLI Versus SF-36
verfasst von:
Hon-Yi Shi, Hao-Hsien Lee, Chong-Chi Chiu, Herng-Chia Chiu, Yih-Huei Uen, King-Teh Lee
Erschienen in:
Journal of Gastrointestinal Surgery
|
Ausgabe 7/2008
Einloggen, um Zugang zu erhalten
Abstract
Introduction
To compare responsiveness and minimal clinically important differences (MCID) between the Gastrointestinal Quality of Life (GIQLI) and the Short Form 36 (SF-36), we prospectively analyze 159 patients undergoing cholecystectomy at two tertiary academic hospitals.
Patients and Methods
All patients completed the disease-specific GIQLI and the generic SF-36 before and 3 months after surgery. Scores using these instruments were interpreted by generalized estimating equation before and after cholecystectomy. The bootstrap estimation was used to derive 95% confidence intervals for differences in the responsiveness estimates.
Results and Discussion
Mean changes in all GIQLI and the SF-36 subscales were statistically significant (p < 0.05). Comparisons of effect size (ES), standardized response means (SRM), and relative efficiency (>1) indicated that the responsiveness of the GIQLI was superior to that of the SF-36. In the equivalence test, all lower or upper confidence limits presented no equivalence (>5), indicating good MCID. The ES and SRM for emotions and physical function in the GIQLI significantly differed from those of the SF-36 (p < 0.05).
Conclusion
The data in this study indicate that clinicians and health researchers should weight disease-specific measures more heavily than generic measures when evaluating treatment outcomes.